
Last Price
52 Week Range
$10.21 - $10.76
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | $386.69M |
EV | $386.99M |
Shares Outstanding | 35.94M |
Beta | - |
Industry | Shell Companies |
Analyst Rating | - |
Analyst Target Price | - |
Number of Analysts | 0 |
P/E E | - |
P/B E | - |
Revenue | - |
EBIT | - |
EPS | - |
BVPS | - |
Revenue | - |
EBIT | - |
EPS | - |
BVPS | - |
Ebit Margin E | - |
Net Profit Margin E | - |
ROE E | - |
ROA E | - |
DPS E | - |
Payout Ratio E | - |
Div. Yield E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y

GP-Act III Acquisition Corp.
GPAT
Sector
Financial Services
Industry
Shell Companies
CEO
Bonchristiano, Antonio Carlos Augusto
Employees
Website
www.gp-act3.comIPO Date
Headquarters
300 Park Avenue, 2nd Floor, New York, New York, 10022, United States
The last closing price of GP-Act III Acquisition (GPAT) is $10.77, reflecting a +0.09% change from the prior session. Last updated: February 13, 2026 at 4:02 PM Eastern Time
Review of Recent GPAT Stock Performance trends:Past 1 Month: GP-Act III Acquisition (GPAT) shares changed by +0.37%.Past 3 Months: The stock recorded a change of +1.13%.Past 6 Months: GPAT shares posted a change of +2.28%. Last updated: February 15, 2026 at 5:04 PM Eastern Time
Over the last year, GP-Act III Acquisition (GPAT) has established a 52-week price range between a high of $10.76 and a low of $10.21. This metric is essential for assessing the stock's annual volatility. Last updated: February 15, 2026 at 5:04 PM Eastern Time
The current GP-Act III Acquisition (GPAT) market capitalization is approximately $386.69M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, GP-Act III Acquisition's market cap fluctuates with changes in its share price and share count. Last updated: February 15, 2026 at 5:04 PM Eastern Time
GP-Act III Acquisition's (GPAT) earnings reports, including quarterly and annual financial statements, are available through the company's official regulatory filings with the U.S. Securities and Exchange Commission (SEC). On Gainify, you can access GP-Act III Acquisition's full set of filings, including earnings releases, Form 10-Q, Form 10-K, and other disclosures, in one place: GP-Act III Acquisition SEC Filings These filings provide detailed information on GP-Act III Acquisition's financial performance and are considered the primary source of verified financial data for publicly traded companies.
GP-Act III Acquisition (GPAT) does not currently pay a dividend. Over the last twelve months (LTM), the company paid $0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future.
Based on the latest available analyst coverage, GP-Act III Acquisition (GPAT) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: February 13, 2026 at 4:02 PM Eastern Time
Like other publicly traded stocks, GP-Act III Acquisition (GPAT) shares are bought and sold on stock exchanges such as Nasdaq and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for GP-Act III Acquisition (GPAT) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.
At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add GPAT to your watchlist.
GP-Act III Acquisition trades under the ticker symbol GPAT on the Nasdaq stock exchange. The ticker GPAT is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.
GP-Act III Acquisition (GPAT) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest GP-Act III Acquisition (GPAT) stock peers based on overlapping products, services, and competitive dynamics:Elah Holdings (ELLH)Dynamix (ETHM)Wright Investors' Service Holdings (IWSH)Indigo Acquisition (INAC)Navigator Acquisition (NAQ.P)Pelican Acquisition (PELI) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to GP-Act III Acquisition.
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.